781 ANDROGEN DEPRIVATION THERAPY BY A GONADOTROPIN RELEASING HORMONE ANTAGONIST, DEGARELIX, LOWERS THE RISK OF CARDIOVASCULAR EVENTS OR DEATH WHEN COMPARED TO LUTEINISING HORMONE-RELEASING AGONISTS

✍ Scribed by Albertsen, Peter; Tombal, Bertrand; Wiegel, Thomas; van der Meulen, Egbert; Persson, Bo-Eric; Olesen, Tine Kold; Beckman, Joshua

• Book ID: 123338669
• Publisher: Lippincott Williams and Wilkins
• Year: 2013
• Tongue: English
• Weight: 48 KB
• Volume: 189
• Category: Article
• ISSN: 0022-5347
• DOI: 10.1016/j.juro.2013.02.345